Women with Endometriosis and PCOS lack tailored symptom tracking, actionable patterns, and clinician-ready reports. A privacy-first mobile app that combines daily symptom tracking, AI pattern detection, personalized care plans and community support closes that gap.
Target Audience
Women ages 18–40 diagnosed with Endometriosis or PCOS who actively seek symptom relief, tracking and personalized care; clinics/specialist practices treatingmoderate-to-severe cases for enterprise sales
Market Size
$7.2B = 200M women globally wi...
Competition
medium
Get the complete market analysis, competitor insights, and business recommendations.
Free accounts get access to today's Daily Insight. Paid plans unlock all ideas with full market analysis.
Symptom tracking + personalized care for Endo/PCOS sufferers targets a $7.2B = 200M women globally with Endo/PCOS x $36 ARPU/year total addressable market with medium saturation and a year-over-year growth rate of ~15% digital women's-health growth/year.
Key trends driving demand: Telehealth normalization -- patients and clinicians are comfortable using remote tools and sharing digital symptom logs for care decisions; AI personalization -- modern ML enables detection of individualized symptom patterns and response-to-treatment signals from longitudinal data; Women's-health destigmatization -- increased public awareness and community-driven diagnosis encourages app adoption; Data-driven reimbursement -- payers and employers are piloting digital therapeutics and RPM (remote patient monitoring) for chronic conditions.
Key competitors include Flo, Clue (BioWink), Ovia Health (and Glow), MyEndometriosisTeam / Facebook groups (community workarounds).
Sign in for the full analysis including competitor analysis, revenue model, go-to-market strategy, and implementation roadmap.
Analysis, scores, and revenue estimates are for educational purposes only and are based on AI models. Actual results may vary depending on execution and market conditions.